Patient and doctor consultation.

Royal Cornwall Hospitals NHS Trust contributes to trial showing hope in extending survival for prostate cancer patients

A major international clinical trial has published findings showing that a new combination of drugs can significantly extend the lives of men with advanced prostate cancer. The TALAPRO-2 trial, which included patients from Royal Cornwall Hospitals NHS Trust (RCHT), tested a treatment that could become a new standard of care.

Text Size

Change font

Contrast